Villanueva Adda, Biswas Pooja, Kishaba Kameron, Suk John, Tadimeti Keerti, Raghavendra Pongali B, Nadeau Karine, Lamontagne Bruno, Busque Lambert, Geoffroy Steve, Mongrain Ian, Asselin Géraldine, Provost Sylvie, Dubé Marie-Pierre, Nudleman Eric, Ayyagari Radha
a Retina Department Genomics Institute, Mejora Vision MD/Virtual Eye Care MD , Mérida , Yucatán , México.
b Laboratoire de Diagnostic Moleculaire , Hôpital Maisonneuve Rosemont , Montreal , Quebec , Canada.
Ophthalmic Genet. 2018 Jan-Feb;39(1):73-79. doi: 10.1080/13816810.2017.1373830. Epub 2017 Sep 25.
To investigate the clinical characteristics and genetic basis of inherited retinal degeneration (IRD) in six unrelated pedigrees from Mexico.
A complete ophthalmic evaluation including measurement of visual acuities, Goldman kinetic or Humphrey dynamic perimetry, Amsler test, fundus photography, and color vision testing was performed. Family history and blood samples were collected from available family members. DNA from members of two pedigrees was examined for known mutations using the APEX ARRP genotyping microarray and one pedigree using the APEX LCA genotyping microarray. The remaining three pedigrees were analyzed using a custom-designed targeted capture array covering the exons of 233 known retinal degeneration genes. Sequencing was performed on Illumina HiSeq. Reads were mapped against hg19, and variants were annotated using GATK and filtered by exomeSuite. Segregation and ethnicity-matched control sample analyses were performed by dideoxy sequencing.
Six pedigrees with IRD were analyzed. Nine rare or novel, potentially pathogenic variants segregating with the phenotype were detected in IMPDH1, USH2A, RPE65, ABCA4, and FAM161A genes. Among these, six were known mutations while the remaining three changes in USH2A, RPE65, and FAM161A genes have not been previously reported to be associated with IRD. Analysis of 100 ethnicity-matched controls did not detect the presence of these three novel variants indicating, these are rare variants in the Mexican population.
Screening patients diagnosed with IRD from Mexico identified six known mutations and three rare or novel potentially damaging variants in IMPDH1, USH2A, RPE65, ABCA4, and FAM161A genes that segregated with disease.
研究来自墨西哥的六个无血缘关系家系中遗传性视网膜变性(IRD)的临床特征和遗传基础。
进行了全面的眼科评估,包括视力测量、戈德曼动态视野检查或汉弗莱动态视野检查、阿姆斯勒测试、眼底照相和色觉测试。从可及的家庭成员中收集家族史和血样。使用APEX ARRP基因分型微阵列对两个家系的成员DNA进行已知突变检测,使用APEX LCA基因分型微阵列对一个家系进行检测。其余三个家系使用定制设计的靶向捕获阵列进行分析,该阵列覆盖233个已知视网膜变性基因的外显子。在Illumina HiSeq上进行测序。将 reads 比对到 hg19,并使用GATK注释变体,通过exomeSuite进行过滤。通过双脱氧测序进行分离分析和种族匹配对照样本分析。
对六个IRD家系进行了分析。在IMPDH1、USH2A、RPE65、ABCA4和FAM161A基因中检测到九个与表型共分离的罕见或新的潜在致病变体。其中,六个是已知突变,而USH2A、RPE65和FAM161A基因中的其余三个变化此前未被报道与IRD相关。对100名种族匹配对照的分析未检测到这三个新变体的存在,表明这些是墨西哥人群中的罕见变体。
对来自墨西哥被诊断为IRD的患者进行筛查,在IMPDH1、USH2A、RPE65、ABCA4和FAM161A基因中鉴定出六个已知突变以及三个与疾病共分离的罕见或新的潜在有害变体。